Weill Cornell Newsroom
News From Weill Cornell
(November 25, 2015)
An experimental chemotherapy kills leukemia cells that are abundant in proteins critical to cancer growth.
New Treatment Options for Advanced-Stage Cancer Patients Revealed Through Next-Generation Sequencing Test
(November 13, 2015)
A powerful new test that can reveal untapped therapies for patients with advanced cancers by scanning thousands of their genes will soon be available for patients at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center.
Weill Cornell Medical College and Cellectis Announce Research Alliance Advancing Drug Discovery and the Translation of Novel Immunotherapies in Leukemia
(June 10, 2015)
Weill Cornell Medical College and Cellectis have entered into a strategic translational research alliance to accelerate the development of a targeted immunotherapy for patients with acute myelogenous leukemia, a deadly blood cancer.
Awards & Honors
(November 20, 2015)
Dr. Holly Prigerson wins a 2015 Outstanding Investigator Award from the National Cancer Institute and other awards, honors, prizes and achievements for the week of Nov.13 - Nov. 20.